Literature DB >> 2898584

Bone marrow transplantation in five children with sickle cell anaemia.

C Vermylen1, E Fernandez Robles, J Ninane, G Cornu.   

Abstract

Five children with severe sickle cell anaemia underwent an HLA compatible allogeneic bone marrow transplantation. In four children the engraftment was rapid and sustained. The fifth child rejected the bone marrow graft and required a second bone marrow transplantation 62 days after the first one. The outcome was then uneventful. In all cases there was complete cessation of vaso-occlusive episodes and haemolysis. The haemoglobin electrophoretic pattern became similar to that of the donor (AA or AS) and cytogenetic studies in three patients confirmed the donor origin of bone marrow cells.

Entities:  

Mesh:

Year:  1988        PMID: 2898584     DOI: 10.1016/s0140-6736(88)92239-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche.

Authors:  Gemma M Balmer; Paul R Riley
Journal:  J Cardiovasc Transl Res       Date:  2012-06-15       Impact factor: 4.132

2.  The vaso-occlusive crisis of sickle cell disease.

Authors:  S C Davies
Journal:  BMJ       Date:  1991-06-29

3.  Treatment of sickle cell anemia with bone marrow transplantation-pros and cons.

Authors:  F T Billings
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

4.  Bone marrow transplantation for sickle cell disease.

Authors:  S C Davies
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

Review 5.  Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.

Authors:  Courtney D Fitzhugh; Allistair A Abraham; John F Tisdale; Matthew M Hsieh
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-29       Impact factor: 3.722

Review 6.  [Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy].

Authors:  H Link; H J Kolb; W Ebell; D K Hossfeld; A Zander; D Niethammer; H Wandt; H Grosse-Wilde; U W Schaefer
Journal:  Med Klin (Munich)       Date:  1997-09-15

7.  Effective control of sickle cell disease with hydroxyurea therapy.

Authors:  Harminder Singh; Navin Dulhani; Bithika Nel Kumar; Prabhakar Singh; Pawan Tiwari
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

8.  Bone marrow transplantation in sickle cell anaemia.

Authors:  C Vermylen; G Cornu; M Philippe; J Ninane; A Borja; D Latinne; A Ferrant; J L Michaux; G Sokal
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

Review 9.  Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Curr Opin Oncol       Date:  2009-03       Impact factor: 3.645

10.  Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease.

Authors:  M de Montalembert; P Beauvais; D Bachir; F Galacteros; R Girot
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.